Headlands Technologies LLC Invests $66,000 in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Headlands Technologies LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 860 shares of the company’s stock, valued at approximately $66,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Spinnaker Trust grew its holdings in shares of GE HealthCare Technologies by 5.9% during the fourth quarter. Spinnaker Trust now owns 62,918 shares of the company’s stock worth $4,865,000 after purchasing an additional 3,489 shares during the last quarter. Chapman Investment Management LLC grew its holdings in shares of GE HealthCare Technologies by 0.7% during the fourth quarter. Chapman Investment Management LLC now owns 88,673 shares of the company’s stock worth $6,856,000 after purchasing an additional 614 shares during the last quarter. WD Rutherford LLC grew its holdings in shares of GE HealthCare Technologies by 61.0% during the fourth quarter. WD Rutherford LLC now owns 6,085 shares of the company’s stock worth $454,000 after purchasing an additional 2,305 shares during the last quarter. AM Investment Strategies LLC grew its holdings in shares of GE HealthCare Technologies by 16.3% during the fourth quarter. AM Investment Strategies LLC now owns 23,236 shares of the company’s stock worth $1,797,000 after purchasing an additional 3,254 shares during the last quarter. Finally, Bailard Inc. bought a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $204,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ:GEHC opened at $76.24 on Wednesday. The company has a quick ratio of 0.83, a current ratio of 1.05 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The stock’s 50 day moving average is $88.98 and its 200-day moving average is $78.75. The firm has a market capitalization of $34.79 billion, a price-to-earnings ratio of 25.25, a PEG ratio of 3.00 and a beta of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up 5.3% on a year-over-year basis. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies’s payout ratio is 3.97%.

Analysts Set New Price Targets

Several analysts recently commented on the company. Argus upped their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. Citigroup upped their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. HSBC assumed coverage on GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their target price for the company from $66.00 to $88.00 in a report on Monday, February 12th. Finally, Mizuho upped their target price on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.